AI: The Sleeping Giant in Biopharma
AI is poised to revolutionize the biopharmaceutical industry, promising to reduce drug development time by up to 10X and improve clinical trial efficiency. However, the road to widespread adoption is slower than anticipated due to regulatory complexities and the intricate nature of the pharmaceutical landscape.
Jan 10